February 14, 2019, 01:17 pm

PureTech's Vor Biopharma raises $42M for blood cancer drugs


 14-02-2019 1:17 PM

Boston biotech Vor Biopharma, a company whose science is based on one of the world's best-known cancer doctors, this morning announced that it received a $42 million Series A round of investment led by 5AM Ventures and RA Capital Management. Other investors in the startup, which was co-founded...

Posted in: Cities: Tags:
Boston Business Journal
Boston Business Journal

This article was posted online by Boston Business Journal. NewsChamber collects excepts of news articles from this news source and add these in the 'Massachusetts Business'-category.

This story was posted in the category: